J.P. Morgan and BofA Merrill Lynch, William Blair and Stifel to assist
By Devika Patel
Knoxville, Tenn., June 4 – EndoChoice said it priced its $95.25 million initial public offering of stock with a $14.29 million greenshoe.
The company will sell 6.35 million common shares at $15.00 per share.
J.P. Morgan and BofA Merrill Lynch are the bookrunners.
Settlement is expected on June 10.
Based in Atlanta, the medical technology company makes and sells technologies for screening, diagnosing and treating gastrointestinal conditions. The company intends to list its common stock on the NYSE exchange under the symbol “GI.”
| Issuer: | EndoChoice
|
| Issue: | Common stock
|
| Amount: | $95.25 million
|
| Greenshoe: | $14,287,500, or 952,500 shares
|
| Shares: | 6.35 million
|
| Price: | $15.00
|
| Warrants: | No
|
| Bookrunners: | J.P. Morgan and BofA Merrill Lynch
|
| Co-managers: | William Blair and Stifel
|
| Pricing date: | June 4
|
| Settlement date: | June 10
|
| Stock exchange: | NYSE: GI
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
